Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday granted emergency-use authorization to Inflarx NV's monoclonal antibody for the treatment of hospitalized COVID patients when ...

As the number of coronavirus cases increases, again, there's high demand for emergency-use monoclonal antibodies that successfully combat COVID-19. Casirivimab, imdevimab bamlanivimab, etesevimab and ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND, Ohio (KFOR/Storyful) – Desperate ...

Early studies hint that a nerve block in the neck could help restore long COVID patients' sense of smell, but more research is needed. When you purchase through links on our site, we may earn an ...

The regional infusion center for Southeast Texas has received a new federal notice, which will force the center to further restrict the patients who may receive the potentially-lifesaving COVID ...

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...

Researchers from Philadelphia-based Jefferson Health have discovered that an injection of anesthetic to specific nerves in the neck may be able to improve loss of smell and taste associated with long ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...